September 13, 2021
The Pharmaceuticals and Medical Devices Agency (PMDA) is investigating new side effect risks for the antiparasitic agent ivermectin (brand name: Stromectol) and two other drugs, a move likely to trigger label changes in the near future. According to a risk...read more